GUARDIAN DRUG COMPANY, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan GUARDIAN DRUG COMPANY 401(K) PLAN
Measure | Date | Value |
---|
2022: GUARDIAN DRUG COMPANY 401(K) PLAN 2022 401k membership |
---|
Total participants, beginning-of-year | 2022-01-01 | 98 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 96 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 18 |
Total of all active and inactive participants | 2022-01-01 | 114 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 0 |
Total participants | 2022-01-01 | 114 |
Number of participants with account balances | 2022-01-01 | 78 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 2 |
2021: GUARDIAN DRUG COMPANY 401(K) PLAN 2021 401k membership |
---|
Total participants, beginning-of-year | 2021-01-01 | 94 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 87 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 11 |
Total of all active and inactive participants | 2021-01-01 | 98 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 0 |
Total participants | 2021-01-01 | 98 |
Number of participants with account balances | 2021-01-01 | 72 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 1 |
2020: GUARDIAN DRUG COMPANY 401(K) PLAN 2020 401k membership |
---|
Total participants, beginning-of-year | 2020-01-01 | 96 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 86 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 8 |
Total of all active and inactive participants | 2020-01-01 | 94 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 0 |
Total participants | 2020-01-01 | 94 |
Number of participants with account balances | 2020-01-01 | 67 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 1 |
2019: GUARDIAN DRUG COMPANY 401(K) PLAN 2019 401k membership |
---|
Total participants, beginning-of-year | 2019-01-01 | 93 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 86 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 10 |
Total of all active and inactive participants | 2019-01-01 | 96 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 0 |
Total participants | 2019-01-01 | 96 |
Number of participants with account balances | 2019-01-01 | 67 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 2 |
2018: GUARDIAN DRUG COMPANY 401(K) PLAN 2018 401k membership |
---|
Total participants, beginning-of-year | 2018-01-01 | 89 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 85 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 8 |
Total of all active and inactive participants | 2018-01-01 | 93 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 0 |
Total participants | 2018-01-01 | 93 |
Number of participants with account balances | 2018-01-01 | 64 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 1 |
2017: GUARDIAN DRUG COMPANY 401(K) PLAN 2017 401k membership |
---|
Total participants, beginning-of-year | 2017-01-01 | 84 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 80 |
Number of retired or separated participants receiving benefits | 2017-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 9 |
Total of all active and inactive participants | 2017-01-01 | 89 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 0 |
Total participants | 2017-01-01 | 89 |
Number of participants with account balances | 2017-01-01 | 63 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 0 |
Measure | Date | Value |
---|
2022 : GUARDIAN DRUG COMPANY 401(K) PLAN 2022 401k financial data |
---|
Transfers to/from the plan | 2022-12-31 | $0 |
Total plan liabilities at end of year | 2022-12-31 | $0 |
Total plan liabilities at beginning of year | 2022-12-31 | $0 |
Total income from all sources | 2022-12-31 | $-235,164 |
Expenses. Total of all expenses incurred | 2022-12-31 | $235,204 |
Benefits paid (including direct rollovers) | 2022-12-31 | $231,578 |
Total plan assets at end of year | 2022-12-31 | $4,587,469 |
Total plan assets at beginning of year | 2022-12-31 | $5,057,837 |
Value of fidelity bond covering the plan | 2022-12-31 | $500,000 |
Assets. Value of tangible personal property | 2022-12-31 | $0 |
Total contributions received or receivable from participants | 2022-12-31 | $615,926 |
Assets. Value of loans (other than to participants) | 2022-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2022-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2022-12-31 | $85,218 |
Other income received | 2022-12-31 | $-1,047,516 |
Noncash contributions received | 2022-12-31 | $0 |
Net income (gross income less expenses) | 2022-12-31 | $-470,368 |
Net plan assets at end of year (total assets less liabilities) | 2022-12-31 | $4,587,469 |
Net plan assets at beginning of year (total assets less liabilities) | 2022-12-31 | $5,057,837 |
Assets. Value of participant loans | 2022-12-31 | $8,428 |
Assets. Value of assets in partnership/joint-venture interests | 2022-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2022-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2022-12-31 | $0 |
Assets. Value of employer securities | 2022-12-31 | $0 |
Assets. Value of employer real property | 2022-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2022-12-31 | $111,208 |
Value of certain deemed distributions of participant loans | 2022-12-31 | $0 |
Value of corrective distributions | 2022-12-31 | $2,075 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2022-12-31 | $1,551 |
2021 : GUARDIAN DRUG COMPANY 401(K) PLAN 2021 401k financial data |
---|
Transfers to/from the plan | 2021-12-31 | $0 |
Total plan liabilities at end of year | 2021-12-31 | $0 |
Total plan liabilities at beginning of year | 2021-12-31 | $0 |
Total income from all sources | 2021-12-31 | $1,380,306 |
Expenses. Total of all expenses incurred | 2021-12-31 | $369,053 |
Benefits paid (including direct rollovers) | 2021-12-31 | $354,896 |
Total plan assets at end of year | 2021-12-31 | $5,057,837 |
Total plan assets at beginning of year | 2021-12-31 | $4,046,584 |
Value of fidelity bond covering the plan | 2021-12-31 | $500,000 |
Assets. Value of tangible personal property | 2021-12-31 | $0 |
Total contributions received or receivable from participants | 2021-12-31 | $626,580 |
Assets. Value of loans (other than to participants) | 2021-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2021-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2021-12-31 | $0 |
Other income received | 2021-12-31 | $647,459 |
Noncash contributions received | 2021-12-31 | $0 |
Net income (gross income less expenses) | 2021-12-31 | $1,011,253 |
Net plan assets at end of year (total assets less liabilities) | 2021-12-31 | $5,057,837 |
Net plan assets at beginning of year (total assets less liabilities) | 2021-12-31 | $4,046,584 |
Assets. Value of participant loans | 2021-12-31 | $28,386 |
Assets. Value of assets in partnership/joint-venture interests | 2021-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2021-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2021-12-31 | $0 |
Assets. Value of employer securities | 2021-12-31 | $0 |
Assets. Value of employer real property | 2021-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2021-12-31 | $106,267 |
Value of certain deemed distributions of participant loans | 2021-12-31 | $0 |
Value of corrective distributions | 2021-12-31 | $13,310 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2021-12-31 | $847 |
2020 : GUARDIAN DRUG COMPANY 401(K) PLAN 2020 401k financial data |
---|
Transfers to/from the plan | 2020-12-31 | $0 |
Total plan liabilities at end of year | 2020-12-31 | $0 |
Total plan liabilities at beginning of year | 2020-12-31 | $0 |
Total income from all sources | 2020-12-31 | $1,374,975 |
Expenses. Total of all expenses incurred | 2020-12-31 | $164,263 |
Benefits paid (including direct rollovers) | 2020-12-31 | $160,298 |
Total plan assets at end of year | 2020-12-31 | $4,046,584 |
Total plan assets at beginning of year | 2020-12-31 | $2,835,872 |
Value of fidelity bond covering the plan | 2020-12-31 | $400,000 |
Assets. Value of tangible personal property | 2020-12-31 | $0 |
Total contributions received or receivable from participants | 2020-12-31 | $597,259 |
Assets. Value of loans (other than to participants) | 2020-12-31 | $0 |
Expenses. Other expenses not covered elsewhere | 2020-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2020-12-31 | $1,502 |
Other income received | 2020-12-31 | $688,517 |
Noncash contributions received | 2020-12-31 | $0 |
Net income (gross income less expenses) | 2020-12-31 | $1,210,712 |
Net plan assets at end of year (total assets less liabilities) | 2020-12-31 | $4,046,584 |
Net plan assets at beginning of year (total assets less liabilities) | 2020-12-31 | $2,835,872 |
Assets. Value of participant loans | 2020-12-31 | $47,143 |
Assets. Value of assets in partnership/joint-venture interests | 2020-12-31 | $0 |
Assets. Value of real-estate (other than employer real property) | 2020-12-31 | $0 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2020-12-31 | $0 |
Assets. Value of employer securities | 2020-12-31 | $0 |
Assets. Value of employer real property | 2020-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2020-12-31 | $87,697 |
Value of certain deemed distributions of participant loans | 2020-12-31 | $0 |
Value of corrective distributions | 2020-12-31 | $3,154 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2020-12-31 | $811 |
2019 : GUARDIAN DRUG COMPANY 401(K) PLAN 2019 401k financial data |
---|
Transfers to/from the plan | 2019-12-31 | $0 |
Total plan liabilities at end of year | 2019-12-31 | $0 |
Total plan liabilities at beginning of year | 2019-12-31 | $0 |
Total income from all sources | 2019-12-31 | $1,144,363 |
Expenses. Total of all expenses incurred | 2019-12-31 | $61,823 |
Benefits paid (including direct rollovers) | 2019-12-31 | $60,778 |
Total plan assets at end of year | 2019-12-31 | $2,835,872 |
Total plan assets at beginning of year | 2019-12-31 | $1,753,332 |
Value of fidelity bond covering the plan | 2019-12-31 | $300,000 |
Total contributions received or receivable from participants | 2019-12-31 | $566,047 |
Expenses. Other expenses not covered elsewhere | 2019-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2019-12-31 | $9,881 |
Other income received | 2019-12-31 | $474,182 |
Noncash contributions received | 2019-12-31 | $0 |
Net income (gross income less expenses) | 2019-12-31 | $1,082,540 |
Net plan assets at end of year (total assets less liabilities) | 2019-12-31 | $2,835,872 |
Net plan assets at beginning of year (total assets less liabilities) | 2019-12-31 | $1,753,332 |
Assets. Value of participant loans | 2019-12-31 | $44,393 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2019-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2019-12-31 | $94,253 |
Value of certain deemed distributions of participant loans | 2019-12-31 | $0 |
Value of corrective distributions | 2019-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2019-12-31 | $1,045 |
2018 : GUARDIAN DRUG COMPANY 401(K) PLAN 2018 401k financial data |
---|
Transfers to/from the plan | 2018-12-31 | $0 |
Total plan liabilities at end of year | 2018-12-31 | $0 |
Total plan liabilities at beginning of year | 2018-12-31 | $0 |
Total income from all sources | 2018-12-31 | $453,233 |
Expenses. Total of all expenses incurred | 2018-12-31 | $66,485 |
Benefits paid (including direct rollovers) | 2018-12-31 | $58,641 |
Total plan assets at end of year | 2018-12-31 | $1,753,332 |
Total plan assets at beginning of year | 2018-12-31 | $1,366,584 |
Value of fidelity bond covering the plan | 2018-12-31 | $178,400 |
Total contributions received or receivable from participants | 2018-12-31 | $496,703 |
Expenses. Other expenses not covered elsewhere | 2018-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2018-12-31 | $0 |
Other income received | 2018-12-31 | $-131,493 |
Noncash contributions received | 2018-12-31 | $0 |
Net income (gross income less expenses) | 2018-12-31 | $386,748 |
Net plan assets at end of year (total assets less liabilities) | 2018-12-31 | $1,753,332 |
Net plan assets at beginning of year (total assets less liabilities) | 2018-12-31 | $1,366,584 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2018-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2018-12-31 | $88,023 |
Value of certain deemed distributions of participant loans | 2018-12-31 | $0 |
Value of corrective distributions | 2018-12-31 | $7,492 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2018-12-31 | $352 |
2017 : GUARDIAN DRUG COMPANY 401(K) PLAN 2017 401k financial data |
---|
Transfers to/from the plan | 2017-12-31 | $0 |
Total plan liabilities at end of year | 2017-12-31 | $0 |
Total plan liabilities at beginning of year | 2017-12-31 | $0 |
Total income from all sources | 2017-12-31 | $631,055 |
Expenses. Total of all expenses incurred | 2017-12-31 | $10,893 |
Benefits paid (including direct rollovers) | 2017-12-31 | $10,668 |
Total plan assets at end of year | 2017-12-31 | $1,366,584 |
Total plan assets at beginning of year | 2017-12-31 | $746,422 |
Value of fidelity bond covering the plan | 2017-12-31 | $178,400 |
Total contributions received or receivable from participants | 2017-12-31 | $412,591 |
Expenses. Other expenses not covered elsewhere | 2017-12-31 | $0 |
Contributions received from other sources (not participants or employers) | 2017-12-31 | $0 |
Other income received | 2017-12-31 | $152,754 |
Noncash contributions received | 2017-12-31 | $0 |
Net income (gross income less expenses) | 2017-12-31 | $620,162 |
Net plan assets at end of year (total assets less liabilities) | 2017-12-31 | $1,366,584 |
Net plan assets at beginning of year (total assets less liabilities) | 2017-12-31 | $746,422 |
Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2017-12-31 | $0 |
Total contributions received or receivable from employer(s) | 2017-12-31 | $65,710 |
Value of certain deemed distributions of participant loans | 2017-12-31 | $0 |
Value of corrective distributions | 2017-12-31 | $0 |
Expenses. Administrative service providers (salaries,fees and commissions) | 2017-12-31 | $225 |
2022: GUARDIAN DRUG COMPANY 401(K) PLAN 2022 form 5500 responses |
---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2022-01-01 | Plan funding arrangement – Trust | Yes |
2022-01-01 | Plan benefit arrangement - Trust | Yes |
2021: GUARDIAN DRUG COMPANY 401(K) PLAN 2021 form 5500 responses |
---|
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: GUARDIAN DRUG COMPANY 401(K) PLAN 2020 form 5500 responses |
---|
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |
2019: GUARDIAN DRUG COMPANY 401(K) PLAN 2019 form 5500 responses |
---|
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2019-01-01 | Plan funding arrangement – Trust | Yes |
2019-01-01 | Plan benefit arrangement - Trust | Yes |
2018: GUARDIAN DRUG COMPANY 401(K) PLAN 2018 form 5500 responses |
---|
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2018-01-01 | Plan funding arrangement – Trust | Yes |
2018-01-01 | Plan benefit arrangement - Trust | Yes |
2017: GUARDIAN DRUG COMPANY 401(K) PLAN 2017 form 5500 responses |
---|
2017-01-01 | Type of plan entity | Single employer plan |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2017-01-01 | Plan funding arrangement – Trust | Yes |
2017-01-01 | Plan benefit arrangement - Trust | Yes |